Evidence map›Paper›PMID 38633015›Full record

ArticleInfectious diseases & clinical microbiology2023

Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19.

Uluhan Sili, Pınar Ay, Hüseyin Bilgin, Ahmet Topuzoğlu, Elif Tükenmez-Tigen, Buket Ertürk-Şengel, Dilek Yağçı-Çağlayık, Baran Balcan, Derya Kocakaya, Şehnaz Olgun-Yıldızeli and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Infectious diseases & clinical microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Uluhan SiliDepartment of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-9939-9298
Pınar AyDepartment of Public Health, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-3303-1343
Hüseyin BilginDepartment of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-5048-9970
Ahmet TopuzoğluDepartment of Public Health, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-7497-548X
Elif Tükenmez-TigenDepartment of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-2027-4116
Buket Ertürk-ŞengelDepartment of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-2182-4693
Dilek Yağçı-ÇağlayıkDepartment of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-3473-8073
Baran BalcanDepartment of Pulmonary Medicine, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-1804-1970
Derya KocakayaDepartment of Pulmonary Medicine, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-2910-6813
Şehnaz Olgun-YıldızeliDepartment of Pulmonary Medicine, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-3236-3995
Fethi GülDepartment of Anesthesiology and Intensive Care, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-6426-6436
Beliz BilgiliDepartment of Anesthesiology and Intensive Care, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-3466-0771
Rabia Can-SarınoğluDepartment of Medical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0001-9222-8659
Ayşegül Karahasan-YağcıDepartment of Medical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-1560-2624
Lütfiye Mülazimoğlu-DurmuşoğluDepartment of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0001-6973-473X
Emel EryükselDepartment of Pulmonary Medicine, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-2194-8066
Zekaver OdabaşıDepartment of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0001-8091-6999
Haner DireskeneliDepartment of Internal Medicine, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-2598-5806
Sait KarakurtDepartment of Pulmonary Medicine, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-6699-5798
Volkan KortenDepartment of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-9991-814X
Marmara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to define the predictors of critical illness development within 28 days postadmission during the first wave of the COVID-19 pandemic. Materials and Methods: We conducted a prospective cohort study including 477 PCR-positive COVID-19 patients admitted to a tertiary care hospital in Istanbul from March 12 to May 12, 2020. Results: The most common presenting symptoms were cough, dyspnea, and fatigue. Critical illness developed in 45 (9.4%; 95% CI=7.0%-12.4%) patients. In the multivariable analysis, age (hazard ratio (HR)=1.05, Conclusion: Age, comorbidity number, the WHO scale, LDH, and procalcitonin were independently associated with critical illness development. Mortality from COVID-19 seemed to be decreasing as the first wave of the pandemic advanced. Graphic Abstract: Graphic Abstract.

Indexed as

COVID-19critical illnessprognosisprospective cohort

Identifiers

PMID38633015
PMCPMC10985825
OpenAlexW4382893826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.